Skip to main content
. 2018 Apr 28;31(4):480–490. doi: 10.20524/aog.2018.0266

Figure 5.

Figure 5

Forest plots of rates of hepatitis B virus (HBV) reactivation between HBsAg-negative, anti-HBc-positive patients treated with and without rituximab-containing regimens

RR, relative risk; 95%CI, 95% confidence interval.